Nom du produit:2-(3,4-dimethoxyphenyl)ethanamine;hydrochloride
IUPAC Name:2-(3,4-dimethoxyphenyl)ethan-1-amine hydrochloride
- CAS：635-85-8
- Formule moléculaire：C10H16ClNO2
- Pureté：95%+
- Numéro de catalogue：CM661081
- Poids moléculaire：217.69
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:635-85-8
- Formule moléculaire:C10H16ClNO2
- Point de fusion:-
- Code SMILES:Cl.COC1=C(OC)C=C(CCN)C=C1
- Densité:
- Numéro de catalogue:CM661081
- Poids moléculaire:217.69
- Point d'ébullition:
- N° Mdl:MFCD00039058
- Stockage:
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Ensifentrine
- Verona Pharma's Ensifentrine was accepted for NDA Review by FDA for chronic obstructive pulmonary disease (COPD) maintenance treatment. COPD is used to describe chronic lung diseases, encompassing emphysema, and chronic bronchitis. Phase 3 ENHANCE trials demonstrated Ensifentrine's efficacy and safety, showing significant improvements in lung function, symptom endpoints, and reducing the rate and risk of COPD exacerbations. Ensifentrine offers a novel mechanism of action. It is a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4); it is also an activator of the cystic fibrosis transmembrane conductance regulator (CFTR).
Recherche 
+86 21 5895 0110 
